INTERNATIONAL PATENT: APMONIA THERAPEUTICS FILES APPLICATION FOR "FORMULATIONS OF PEPTIDES INHIBITING THE TSP-CD47 INTERACTION"

GENEVA, May 12 -- APMONIA THERAPEUTICS (MDA, 2 rue Leon Patoux51100 Reims) filed a patent application (PCT/EP2024/080846) for "FORMULATIONS OF PEPTIDES INHIBITING THE TSP-CD47 INTERACTION" on Oct 31, 2024. With publication no. WO/2025/093688, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JEANNE, Albin (c/o APMONIA THERAPEUTICSMDA, 2 rue Leon Patoux51100 Reims), LACHGAR, Abderrahim (c/o APMONIA THERAPEUTICSMDA, 2 rue Leon Patoux51100 Reims), DEDIEU, Stephane (c/o APMONIA THERAPEUTICSMDA, 2 rue Leon Patoux51100 Reims), MO...